Phathom Pharmaceuticals Inc (PHAT): Next-Year EPS Estimate 291.03%
As of 2026-06-11, Phathom Pharmaceuticals Inc (PHAT) has a next-year EPS growth estimate of 291.03%.
On 2026-05-17, analyst consensus for PHAT's next-year EPS growth shifted from 321.63% to 291.03% — a negative change of 30.60 percentage points. The revised estimate has been sustained across 20 subsequent trading sessions. Current-year growth is projected at 79.43%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 291.03%
- EPS growth this year
- 79.43%
- EPS next quarter (est)
- -$0.20
- Last price
- $10.27
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-11 | 291.03% | 79.43% | -$0.20 | $10.27 |
| 2026-06-10 | 291.03% | 79.43% | -$0.20 | $9.82 |
| 2026-06-09 | 291.03% | 79.43% | -$0.20 | $9.82 |
| 2026-06-08 | 291.03% | 79.43% | -$0.20 | $10.00 |
| 2026-06-07 | 291.03% | 79.43% | -$0.20 | $10.13 |
| 2026-06-04 | 291.03% | 79.43% | -$0.20 | $9.86 |
| 2026-06-03 | 291.03% | 79.43% | -$0.20 | $10.09 |
| 2026-06-02 | 291.03% | 79.43% | -$0.20 | $9.65 |
| 2026-06-01 | 291.03% | 79.43% | -$0.20 | $9.24 |
| 2026-05-31 | 291.03% | 79.43% | -$0.20 | $9.59 |
| 2026-05-28 | 291.03% | 79.43% | -$0.20 | $10.32 |
| 2026-05-27 | 291.03% | 79.43% | -$0.20 | $10.74 |
| 2026-05-26 | 291.03% | 79.43% | -$0.20 | $11.10 |
| 2026-05-25 | 291.03% | 79.43% | -$0.20 | $11.33 |
| 2026-05-24 | 291.03% | 79.43% | -$0.20 | $11.33 |
| 2026-05-21 | 291.03% | 79.43% | -$0.20 | $11.58 |
| 2026-05-20 | 291.03% | 79.43% | -$0.20 | $11.87 |
| 2026-05-19 | 291.03% | 79.43% | -$0.20 | $11.40 |
| 2026-05-18 | 291.03% | 79.43% | -$0.20 | $11.39 |
| 2026-05-17 | 291.03% | 79.43% | -$0.20 | $11.87 |
| 2026-05-14 | 321.63% | 82.13% | -$0.20 | $13.05 |
| 2026-05-13 | 321.63% | 82.13% | -$0.20 | $12.70 |
| 2026-05-12 | 321.63% | 82.13% | -$0.20 | $12.53 |
| 2026-05-11 | 321.63% | 82.13% | -$0.20 | $12.22 |
| 2026-05-10 | 321.63% | 82.13% | -$0.20 | $12.16 |
| 2026-05-07 | 321.63% | 82.13% | -$0.20 | $12.23 |
| 2026-05-06 | 321.63% | 82.13% | -$0.20 | $12.67 |
| 2026-05-05 | 321.63% | 82.13% | -$0.20 | $12.60 |
| 2026-05-04 | 321.63% | 82.13% | -$0.20 | $12.87 |
| 2026-05-03 | 321.63% | 82.13% | -$0.20 | $12.01 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Phathom Pharmaceuticals Inc's next-year EPS growth estimate?▾
As of 2026-06-11, Phathom Pharmaceuticals Inc (PHAT) has a next-year EPS growth estimate of 291.03%, based on analyst consensus.
When was the latest EPS estimate revision for PHAT?▾
The most recent revision occurred on 2026-05-17, when analysts adjusted the next-year EPS growth estimate from 321.63% to 291.03%.
What sector and industry does Phathom Pharmaceuticals Inc belong to?▾
Phathom Pharmaceuticals Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. PHAT appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Phathom Pharmaceuticals Inc (PHAT) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports